BEIJING, Jan. 9, 2014 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, announced that it has received approval from the Chinese State Food and Drug Administration for its second generation DHR998 Sleep Diagnostic Device. Dehaier has now formed a comprehensive line of products to address the market demands of sleep diagnosis, sleep apnea treatment and CPAP treatment evaluation. This product portfolio should be introduced for sale in early 2014.
Help employers find you! Check out all the jobs and post your resume.